Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-Bromo-5-methoxybenzenethiol | C7H7BrOS | 13993-51-6 | Details |
| Praliciguat | C21H14F8N6O2 | 1628730-49-3 | Details |
| 4-Bromo-5-methoxypicolinaldehyde | C7H6BrNO2 | 1289092-48-3 | Details |
| Tert-butyl (3R,4R)-4-(aminomethyl)-3-hydroxypiperidine-1-carboxylate | C11H22N2O3 | 1932053-73-0 | Details |
| (5-(Ethylsulfonyl)pyridin-2-yl)methanamine hydrochloride | C8H13ClN2O2S | 1637311-15-9 | Details |
| Pyrithione | C5H5NOS | 1121-30-8 | Details |
| Lipofermata | C15H10BrN3OS | 297180-15-5 | Details |
| 2-Bromo-5-(oxan-4-yl)-1,3,4-thiadiazole | C7H9BrN2OS | 1340436-02-3 | Details |
| Decamethoxine | C38H74ClN2O4+ | 38146-42-8 | Details |
| A2793 | C13H12ClNO3 | 88349-90-0 | Details |
| Pizuglanstat | C27H36N6O4 | 1244967-98-3 | Details |
| Formoterol EP Impurity C | C20H26N2O4 | 1795135-61-3 | Details |
| Formoterol EP Impurity D | C20H26N2O4 | 1795133-96-8 | Details |
| Formoterol Impurity 13 | C18H24N2O3 | 150513-24-9 | Details |
| 3-AMINO-6-CHLORO-5-METHOXY PYRIDINE | C6H7ClN2O | 75711-01-2 | Details |
| Ethyl 4-chloro-6-methylpyrimidine-5-carboxylate | C8H9ClN2O2 | 157981-60-7 | Details |
| CID44216842 | C22H20BrN3O3S | 1222513-26-9 | Details |
| STAT3-IN-1 | C28H29NO6 | 2059952-75-7 | Details |
| Colivelin | C119H206N32O35 | 867021-83-8 | Details |
| BC1618 | C24H24F3NO2 | 2222094-18-8 | Details |
| BD750 | C14H13N3OS | 892686-59-8 | Details |
| LY3405105 | C26H39N7O3 | 2326428-25-3 | Details |
| PFM01 | C14H15NO2S2 | 1558598-41-6 | Details |
| MS140 | C39H40N10O7 | 2229974-83-6 | Details |
| 2-(2-Ethoxyphenoxy)ethanol | C10H14O3 | 3250-73-5 | Details |
| UMB298 | C27H31ClN4O2 | 2266569-73-5 | Details |
| 1,1'-Biphenyl]-4-carboxamide, N-[3-[[(4-fluorophenyl)sulfonyl]amino]-4-hydroxyphenyl]- | C25H19FN2O4S | 2249435-90-1 | Details |
| MK-8719 | C9H14F2N2O3S | 1382799-40-7 | Details |
| KL001 | C21H22N2O4S | 309928-48-1 | Details |
| U 18666A | C25H42ClNO2 | 3039-71-2 | Details |
| (5S,8S,10Ar)-Methyl 5-((tert-butoxycarbonyl)amino)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylate | C16H27N3O5 | 957135-12-5 | Details |
| 6-(4-Ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)-7-fluoro-4-isopropyl-2-(o-tolyl)isoquinolin-1(2H)-one | C24H25FN4O3 | 2511248-11-4 | Details |
| (S)-3-cyclopropyl-3-(2-(((1-(5-methoxy-2-(neopentyl(pyridin-2-yl)carbamoyl)phenyl)piperidin-4-yl)oxy)methyl)pyridin-4-yl)propanoic acid | C35H44N4O5 | 1656261-11-8 | Details |
| 1-Bromo-4-(Difluoromethyl)-2-nitrobenzene | C7H4BrF2NO2 | 1261614-43-0 | Details |
| 7-(Difluoromethyl)-1,2,3,4-Tetrahydroquinoline | C10H11F2N | 1783624-20-3 | Details |
| Tert-Butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate | C13H21NO2 | 301185-41-1 | Details |
| Chloromethyl palmitate | C17H33ClO2 | 61413-69-2 | Details |
| Forsythoside I | C29H36O15 | 1177581-50-8 | Details |
| 1-(4-Bromophenyl)piperidine-4-carboxylic acid | C12H14BrNO2 | 1415794-23-8 | Details |
| Ethyl 1-(4-bromophenyl)piperidine-4-carboxylate | C14H18BrNO2 | 1415794-24-9 | Details |
| BSJ-4-116 | C40H49ClN8O8S | 2519823-34-6 | Details |
| (2R,5S)-Tert-butyl 2-(hydroxymethyl)-5-methylmorpholine-4-carboxylate | C11H21NO4 | 1419222-15-3 | Details |
| CNX-500 | C48H68N10O9S | 1202758-21-1 | Details |
| IWP-O1 | C26H20N6O | 2074607-48-8 | Details |
| Rebamipide Impurity 6 | C19H14Cl2N2O4 | 90098-08-1 | Details |
| Vortioxetine impurity 1 | C17H19ClN2 | 791026-42-1 | Details |
| (5-Chloro-2-ethoxycarbonyl-7-morpholin-4-yl)pyrazolo[1,5-a]pyrimidine | C13H15ClN4O3 | 1232224-64-4 | Details |
| Ralmitaront | C17H22N4O2 | 2133417-13-5 | Details |
| BFCAs-1 | C32H60N4O8 | 585531-74-4 | Details |
| (S,R,S)-AHPC-C6-NH2 dihydrochloride | C29H44ClN5O4S | 2341796-77-6 | Details |
| KEA1-97 | C15H9Cl2FN4 | 2138882-71-8 | Details |
| Methyl tetrazine OH | C9H8N4O | 58884-35-8 | Details |
| 4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine | C16H28BNO3 | 1046793-56-9 | Details |
| trans-2-Ethoxyvinylboronic acid pinacol ester | C10H19BO3 | 1360111-87-0 | Details |
| Thalidomide-linker 6 hydrochloride | C15H16ClN3O5 | 2341840-99-9 | Details |
| (S,R,S)-AHPC-C9-NH2 hydrochloride | C32H50ClN5O4S | 2376139-50-1 | Details |
| Regorafenib D3 | C21H12ClD3F4N4O3 | 1255386-16-3 | Details |
| Quetiapine Sulfoxide | C21H25N3O3S | 329216-63-9 | Details |
| (4-(Thiophen-2-yl)phenyl)methanol | C11H10OS | 81443-44-9 | Details |
| SB 203186 hydrochloride | C16H20N2O2 | 135938-17-9 | Details |
| (R)-3-(1-aminoethyl)-5-(trifluoromethyl)aniline hydrochloride | C9H12ClF3N2 | 2488795-56-6 | Details |
| Pomalidomide-C6-NH2 hydrochloride | C19H25ClN4O4 | 2375194-37-7 | Details |
| Fluorinated VHL Spy Molecule 4 | C15H16BrF3N2O3 | 2290526-31-5 | Details |
| Thalidomide-linker 6 | C15H15N3O5 | 390367-50-7 | Details |
| 2,7-Dichloro-9H-carbazole | C12H7Cl2N | 102871-58-9 | Details |
| GnRH antagonist 2 | C28H27F2N9O5 | 1709823-61-9 | Details |
| (S,S,S)-AHPC hydrochloride | C22H31ClN4O3S | 2115897-23-7 | Details |
| Ethyl 2-allylpent-4-enoate | C10H16O2 | 18325-74-1 | Details |
| (S,R,S)-AHPC-PEG3-Alkyne | C32H44N4O7S | 2374122-30-0 | Details |
| CRT0273750 | C25H22ClF3N4O2 | 1979939-16-6 | Details |
| I3MT-3 | C17H14N2O2S | 459420-09-8 | Details |
| 5-(Oxan-4-yl)-1,3,4-thiadiazol-2-amine | C7H11N3OS | 1343013-17-1 | Details |
| 5-Fluoropyridine-2-carboxylic acid tert-butyl ester | C10H12FNO2 | 1379037-04-3 | Details |
| Spiro[1,3-dioxolane-2,5'-1,4,6,7-tetrahydroindazole | C9H12N2O2 | 1160245-61-3 | Details |
| Methyl 5-bromopyrazolo[1,5-a]pyridine-2-carboxylate | C9H7BrN2O2 | 1822671-53-3 | Details |
| Ruplizumab | 220651-94-5 | Details |
| SCR130 | C19H13Cl2N3O2S | 2377858-38-1 | Details |
| Parsaclisib hydrochloride | C20H23Cl2FN6O2 | 1995889-48-9 | Details |
| Pomalidomide-C6-PEG1-C3-PEG1-butyl iodide | C30H42IN3O7 | 1835705-76-4 | Details |
| Ethyl 4-bromo-6-methoxypyrazolo[1,5-A]pyridine-3-carboxylate | C11H11BrN2O3 | 1416439-70-7 | Details |
| Yakuchinone B | C20H22O3 | 81840-57-5 | Details |
| 1,3,2-Dioxaborolane, 2-[3-(methoxymethoxy)-8-[2-[tris(1-methylethyl)silyl]ethynyl]-1-naphthalenyl]-4,4,5,5-tetramethyl- | C29H43BO4Si | 2621932-42-9 | Details |
| 4-Fluoro-3-methoxy-N-methylbenzenamine | C8H10FNO | 904321-01-3 | Details |
| N-Boc-4-carboxymethoxypiperidine | C12H21NO5 | 161948-70-5 | Details |
| 2-Bromo-5-methylbenzenethiol | C7H7BrS | 19693-10-8 | Details |
| Propranolol D7 hydrochloride | C16H22ClNO2 | 1613439-56-7 | Details |
| 4(1H)-Pyridinone,2-[(acetyloxy)methyl]-5-(phenylmethoxy)- | C15H15NO4 | 959616-78-5 | Details |
| 1,3-Benzenedisulfonamide | C6H8N2O4S2 | 3701-01-7 | Details |
| SU0268 | C26H25N3O4S | 2210228-45-6 | Details |
| Shepherdin | C41H64N12O12S | 861224-28-4 | Details |
| DBCO-trifluoroacetyl-amine | C20H15F3N2O2 | 1337920-23-6 | Details |
| N-[3-[(4-fluorophenyl)sulfonylamino]-4-methoxyphenyl]-4-phenylbenzamide | C26H21FN2O4S | 727699-84-5 | Details |
| CDK4 inhibitor compound 12 | C34H38FN9O3 | 2105956-77-0 | Details |
| Repaglinide-ethyl-d5 | C27H38N2O4 | 1217709-85-7 | Details |
| CDD3505 | C22H17N3O2 | 173865-33-3 | Details |
| APT-api-imC | Details |
| 1,8-Diazaspiro[4.5]decan-2-one hydrochloride | C8H15ClN2O | 1389313-57-8 | Details |
| SB1317 | C23H24N4O | 1204918-72-8 | Details |
| 4-Formyl-n,n-dimethylbenzamide | C10H11NO2 | 58287-76-6 | Details |
| Ethyl 6-bromo-3-hydroxy-5-methylpyrazine-2-carboxylate | C8H9BrN2O3 | 1269026-22-3 | Details |
| Product Total： Product Page： | ||||
| 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||